Quadrant Capital Group LLC Revance Therapeutics, Inc. Transaction History

Quadrant Capital Group LLC

  • $1.42 Billion
  • Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 434 shares of RVNC stock, worth $1,115. This represents 0.0% of its overall portfolio holdings.

Number of Shares
434
Holding current value
$1,115
% of portfolio
0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$2.57 - $2.57 $1,115 - $1,115
434 New
434 $1,000
Q1 2024

May 15, 2024
SELL
$4.65 - $9.31 $920 - $1,843
-198 Reduced 33.11%
400 $1,000
Q4 2023

Feb 08, 2024
BUY
$5.81 - $11.2 $2,643 - $5,096
455 Added 318.18%
598 $5,000
Q3 2023

Nov 14, 2023
SELL
$11.47 - $25.07 $252 - $551
-22 Reduced 13.33%
143 $1,000
Q2 2023

Aug 09, 2023
BUY
$24.7 - $37.61 $172 - $263
7 Added 4.43%
165 $4,000
Q1 2023

May 11, 2023
SELL
$18.36 - $35.27 $36 - $70
-2 Reduced 1.25%
158 $5,000
Q4 2022

Feb 10, 2023
SELL
$18.32 - $30.66 $1,025 - $1,716
-56 Reduced 25.93%
160 $2,000
Q2 2022

Aug 09, 2022
SELL
$11.52 - $20.4 $472 - $836
-41 Reduced 15.95%
216 $3,000
Q1 2022

May 06, 2022
SELL
$12.36 - $20.31 $741 - $1,218
-60 Reduced 18.93%
257 $5,000
Q4 2021

Feb 01, 2022
BUY
$12.46 - $27.87 $2,541 - $5,685
204 Added 180.53%
317 $5,000
Q3 2021

Nov 12, 2021
BUY
$25.78 - $33.21 $128 - $166
5 Added 4.63%
113 $3,000
Q2 2021

Aug 09, 2021
SELL
$26.8 - $31.84 $2,948 - $3,502
-110 Reduced 50.46%
108 $3,000
Q2 2020

Aug 13, 2020
SELL
$12.6 - $26.55 $85,705 - $180,593
-6,802 Reduced 96.89%
218 $5,000
Q1 2020

May 15, 2020
BUY
$12.46 - $27.81 $112 - $250
9 Added 0.13%
7,020 $104,000
Q3 2019

Oct 24, 2019
BUY
$10.22 - $14.5 $71,652 - $101,659
7,011 New
7,011 $89,000
Q2 2019

Jul 24, 2019
SELL
$10.67 - $15.49 $15,770 - $22,894
-1,478 Closed
0 $0
Q1 2019

Apr 29, 2019
BUY
$15.4 - $20.39 $21,175 - $28,036
1,375 Added 1334.95%
1,478 $23,000
Q2 2017

Aug 15, 2017
BUY
N/A
103
103 $2,000

Others Institutions Holding RVNC

# of Institutions
232
Shares Held
83.2M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email